Delivery Order SPE2DB22D3004-SPE2DB25FSD78
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,576.60 on September 10, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This firm fixed-price delivery order, which is not set aside for any particular business category, is scheduled for completion by September 11, 2025, with fulfillment occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $17,864.44 delivery order on August 28, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order represents a discrete fulfillment under the company's existing contract vehicle...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,937.16 for epinephrine 0.15 mg auto-injectors (2-pack) on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,294.20 for Epinephrine 0.15 mg auto-injector (2-pack) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a single delivery order for emergency medical supplies. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,374.28 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price delivery order, which is not set-aside, represents a relatively small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded a $1,907.74 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.15 mg auto-injector two-packs, with completion expected by September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.57 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was issued to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23,377.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $4,178.39 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-inject auto-injectors (2-pack). This competitively awarded, firm fixed-price contract was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSD78Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,494.59 for Epinephrine 0.15 mg auto-injectors (2-pack) on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through the federal medical supply chain to support military and defense healthcare requirements. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal medical procurement standards through competitive awards across multiple therapeutic domains, including specialty medications, vaccines, and medical devices serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 8/25/25 |